Yi, M., Meric-Bernstam, F., Kuerer, H. M., Mittendorf, E. A., Bedrosian, I., Lucci, A., … Hunt, K. K. (2012). Reply to K.J. Van Zee et al. Journal of Clinical Oncology, 30(25), 3144–3145. https://doi.org/10.1200/jco.2012.43.9406

Yi, Min, Funda Meric-Bernstam, Henry M. Kuerer, Elizabeth A. Mittendorf, Isabelle Bedrosian, Anthony Lucci, Rosa F. Hwang, Jaime R. Crow, Sheng Luo, and Kelly K. Hunt. “Reply to K.J. Van Zee et al.” Journal of Clinical Oncology 30, no. 25 (September 1, 2012): 3144–45. https://doi.org/10.1200/jco.2012.43.9406.

Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, et al. Reply to K.J. Van Zee et al. Journal of Clinical Oncology. 2012 Sep 1;30(25):3144–5.

Yi, Min, et al. “Reply to K.J. Van Zee et al.” Journal of Clinical Oncology, vol. 30, no. 25, American Society of Clinical Oncology (ASCO), Sept. 2012, pp. 3144–45. Crossref, doi:10.1200/jco.2012.43.9406.

Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S, Hunt KK. Reply to K.J. Van Zee et al. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012 Sep 1;30(25):3144–3145.